Edwards Lifesciences Corp (NYSE:EW)
$ 89.78 0.64 (0.72%) Market Cap: 54.10 Bil Enterprise Value: 52.72 Bil PE Ratio: 38.70 PB Ratio: 7.60 GF Score: 98/100

Edwards Lifesciences Corp Analyst Event at ACC Scientific Session Transcript

Mar 17, 2019 / 10:00PM GMT
David K. Erickson
Edwards Lifesciences Corporation - VP of IR

Good afternoon. I'm David Erickson, Vice President of Investor Relations at Edwards Lifesciences. I'd like to welcome you to our management Q&A session.

A few housekeeping items before we get started. The event is being webcast live, and a replay will be available on our website as soon as possible after the conclusion. If you have a question, please raise your hand, and we'll bring you a microphone. Please identify yourself before asking your question, and also please limit your questions so we can get to as many people as possible. During this event, Edwards management may make forward-looking statements that involve risks. For information about these risk factors, please refer to documents filed with the SEC that are available on our website at edwards.com.

Finally, the purpose of this event is to discuss the PARTNER III low-risk data presented this weekend. We will defer any updates on the business or to guidance to our Q1 Earnings Call next month.

Representing Edwards management are Mike Mussallem,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot